India Regulator Colluded With Drug Manufacturers, Panel Says
This article is for subscribers only.
India’s top drug regulatory agency violated laws and colluded with pharmaceutical companies to approve medicines without clinical trials, a parliamentary panel said in a report.
The Central Drugs Standard Control Organization which oversees clinical trials and India’s 10,000 drugmakers, approved medicines from companies including Novartis AG, GlaxoSmithKline Plc and Mumbai-based Cipla Ltd. without clinical trials required to be done in the country, the standing committee on health and family welfare said in a report tabled in parliament on May 8.